Marine Forien

755 citations
42 papers · 476 indexed · h-index 13
Topics
Spondyloarthritis Studies and Treatments (14 papers)Gout, Hyperuricemia, Uric Acid (12 papers)Rheumatoid Arthritis Research and Therapies (10 papers)

In The Last Decade

Marine Forien

34 papers receiving 473 citations

Peers

Marine Forien
Comparison fields: 5 of 59
  • Rheumatology 246
  • Surgery 128
  • Nephrology 121
  • Immunology 106
  • Physiology 73
Replace Rıdvan Mercan with:
Rıdvan Mercan Türkiye
Ole Slot Denmark
Alejandro Olivé Spain
Norma Nardi Spain
S. Grootenboer‐Mignot France
Milena Bond Italy
Concepción Castillo Castillo Spain
L. Zakraoui Tunisia
Niccolò Possemato Italy
Soner Şenel Türkiye
Marine Forien relative to Rıdvan Mercan Türkiye Rıdvan Mercan's profile →
Citations per field
00.5×3.8×
Rıdvan Mercan · 1×
Citations per year

Countries citing papers authored by Marine Forien

Since Specialization
Citations

This map shows the geographic impact of Marine Forien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marine Forien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marine Forien more than expected).

Fields of papers citing papers by Marine Forien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marine Forien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marine Forien. The network helps show where Marine Forien may publish in the future.

Co-authorship network of co-authors of Marine Forien

This figure shows the co-authorship network connecting the top 25 collaborators of Marine Forien. A scholar is included among the top collaborators of Marine Forien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marine Forien. Marine Forien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 2
4 2
5 7
6 1
7 8
8 21
9 3
10 37
11 16
12 17
13 5
14 56
15 35
16 0
17 18
18 0
19 8
20 80

About Marine Forien

Marine Forien is a scholar working on Nephrology, Rheumatology and Orthopedics and Sports Medicine, having authored 42 papers that have together received 476 indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (14 papers), Gout, Hyperuricemia, Uric Acid (12 papers) and Rheumatoid Arthritis Research and Therapies (10 papers). The work is most often cited by research in Nephrology (121 citations), Rheumatology (246 citations) and Hematology (62 citations). Marine Forien has collaborated with scholars based in France, Lithuania and Switzerland. Frequent co-authors include Philippe Dieudé, Sébastien Ottaviani, Élisabeth Palazzo, Frédéric Lioté, Yannick Allanore, André Kahan, Esther Ebstein, Christian Roux, Maxime Dougados and Hang‐Korng Ea. Their work appears in journals such as International Journal of Molecular Sciences, Annals of the Rheumatic Diseases and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026